Home / business / Aurobindo Pharma Shares Plunge Over 18% After USFDA’s U-Turn on Unit IV

Aurobindo Pharma Shares Plunge Over 18% After USFDA’s U-Turn on Unit IV

-
On Monday, the US FDA rescinded the VAI letter for the company’s Unit IV in Hyderabad. Aurobindo Pharma said that the inspection is still open, with the status under review.

from Top Business News- News18.com
Read The Rest:timesnownews...
Aurobindo Pharma Shares Plunge Over 18% After USFDA’s U-Turn on Unit IV Aurobindo Pharma Shares Plunge Over 18% After USFDA’s U-Turn on Unit IV Reviewed by Team Exprssnews on February 24, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.